Coronavirus Relief Act Gives Drug Makers New Sway Over FDA
By David S. Hilzenrath, Project on Government Oversight Last year, based on growing concerns about the safety of certain sunscreens, the Food and Drug Administration (FDA) published a plan of action. It proposed concluding that, for two sunscreen ingredients, the risks outweigh the benefits, and it proposed declaring that there was insufficient data to support the […]